UPDATE: Raymond James Downgrades Galena Biopharma (GALE) at Market Perform
Get Alerts GALE Hot Sheet
Price: $0.21 --0%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
(Updated - June 29, 2016 10:56 AM EDT)
(Update correct rating to indicate downgrade)
Raymond James downgraded Galena Biopharma (NASDAQ: GALE) to Market Perform from Outperform.
For an analyst ratings summary and ratings history on Galena Biopharma click here. For more ratings news on Galena Biopharma click here.
Shares of Galena Biopharma closed at $2.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades Sirius XM Radio (SIRI) to Neutral, 'risk-reward is balanced at prevailing levels'
- Benchmark Downgrades Hibbett Sports (HIBB) to Hold
- Guggenheim Downgrades Enphase Energy (ENPH) to Sell
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!